Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-24-001493
Filing Date
2024-11-12
Accepted
2024-11-12 10:20:19
Documents
52
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pktx_10q-093024.htm   iXBRL 10-Q 483624
2 CERTIFICATION ex31x1.htm EX-31.1 11971
3 CERTIFICATION ex31x2.htm EX-31.2 11720
4 CERTIFICATION ex32.htm EX-32 6236
  Complete submission text file 0001079973-24-001493.txt   2746025

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pktx-20240930.xsd EX-101.SCH 23155
6 XBRL CALCULATION FILE pktx-20240930_cal.xml EX-101.CAL 24510
7 XBRL DEFINITION FILE pktx-20240930_def.xml EX-101.DEF 75770
8 XBRL LABEL FILE pktx-20240930_lab.xml EX-101.LAB 217662
9 XBRL PRESENTATION FILE pktx-20240930_pre.xml EX-101.PRE 178534
54 EXTRACTED XBRL INSTANCE DOCUMENT pktx_10q-093024_htm.xml XML 316494
Mailing Address 109 W. MAIN ST. DALTON OH 44618
Business Address 109 W. MAIN ST. DALTON OH 44618 330-445-4971
ProtoKinetix, Inc. (Filer) CIK: 0001128189 (see all company filings)

EIN.: 943355026 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32917 | Film No.: 241444731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)